发明申请
US20090226449A1 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921, and 33751 molecules and uses therefor
审中-公开
小分子18607,15603,69318,12303,48000,52202,5333,35554,57301,58324,55063,52991,59914,59921和33751分子及其用途
- 专利标题： Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921, and 33751 molecules and uses therefor
- 专利标题（中）： 小分子18607,15603,69318,12303,48000,52202,5333,35554,57301,58324,55063,52991,59914,59921和33751分子及其用途
-
申请号： US12381748申请日： 2009-03-16
-
公开(公告)号： US20090226449A1公开(公告)日： 2009-09-10
- 发明人: Maria A. Glucksmann , Rory A.J. Curtis , Jose M. Lora , Katherine M. Galvin , Inmaculada Silos-Santiago
- 申请人： Maria A. Glucksmann , Rory A.J. Curtis , Jose M. Lora , Katherine M. Galvin , Inmaculada Silos-Santiago
- 申请人地址： US MA Cambridge
- 专利权人： Millennium Pharmaceuticals, Inc.
- 当前专利权人： Millennium Pharmaceuticals, Inc.
- 当前专利权人地址： US MA Cambridge
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; C12N15/12 ; C12N5/10 ; C07K14/47 ; C07K16/18 ; C12P21/02 ; C12Q1/68 ; G01N33/566 ; A61K38/17 ; A61K31/7105 ; A61K38/48 ; A61P35/00 ; A61P43/00
摘要：
The invention provides isolated nucleic acids molecules, designated 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 or 33751 gene has been introduced or disrupted. The invention still further provides isolated 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 or 33751 proteins, fusion proteins, antigenic peptides and anti-18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 or 33751 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.
信息查询
